Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells.

Marconi C, Bianchini F, Mannini A, Mugnai G, Ruggieri S, Calorini L.

Clin Exp Metastasis. 2008;25(3):225-31. Epub 2007 Dec 11.

PMID:
18071911
[PubMed - indexed for MEDLINE]
2.

Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9.

Bianchini F, D'Alessio S, Fibbi G, Del Rosso M, Calorini L.

Oncol Rep. 2006 Mar;15(3):709-14.

PMID:
16465434
[PubMed - indexed for MEDLINE]
3.

Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.

Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.

Cancer Res. 2005 Sep 1;65(17):7775-81.

PMID:
16140945
[PubMed - indexed for MEDLINE]
Free Article
4.

The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.

Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K.

Cancer Res. 2005 Mar 15;65(6):2387-96.

PMID:
15781654
[PubMed - indexed for MEDLINE]
Free Article
5.

Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.

Tarui T, Andronicos N, Czekay RP, Mazar AP, Bdeir K, Parry GC, Kuo A, Loskutoff DJ, Cines DB, Takada Y.

J Biol Chem. 2003 Aug 8;278(32):29863-72. Epub 2003 May 15.

PMID:
12754207
[PubMed - indexed for MEDLINE]
Free Article
6.

Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential.

Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS.

Circulation. 2002 Oct 29;106(18):2372-8.

PMID:
12403669
[PubMed - indexed for MEDLINE]
Free Article
7.

Expression of the urokinase plasminogen activator receptor is transiently required during "priming" of PC12 cells in nerve growth factor-directed cellular differentiation.

Farias-Eisner R, Vician L, Reddy S, Basconcillo R, Rabbani SA, Wu YY, Bradshaw RA, Herschman HR.

J Neurosci Res. 2001 Feb 15;63(4):341-6.

PMID:
11170184
[PubMed - indexed for MEDLINE]
8.

Searching for depolarization-induced genes that modulate synaptic plasticity and neurotrophin-induced genes that mediate neuronal differentiation.

Herschman HR, Ferguson GD, Feldman JD, Farias-Eisner R, Vician L.

Neurochem Res. 2000 May;25(5):591-602.

PMID:
10905620
[PubMed - indexed for MEDLINE]
9.

Urokinase receptor (uPAR, CD87) is a platelet receptor important for kinetics and TNF-induced endothelial adhesion in mice.

Piguet PF, Vesin C, Donati Y, Tacchini-Cottier F, Belin D, Barazzone C.

Circulation. 1999 Jun 29;99(25):3315-21.

PMID:
10385508
[PubMed - indexed for MEDLINE]
Free Article
10.

Vitronectin binding to urokinase receptor in human breast cancer.

Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M.

Clin Cancer Res. 1997 Aug;3(8):1299-308.

PMID:
9815812
[PubMed - indexed for MEDLINE]
Free Article
11.

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts.

de Witte H, Pappot H, Brünner N, Grøndahl-Hansen J, Hoyer-Hansen G, Behrendt N, Guldhammer-Skov B, Sweep F, Benraad T, Danø K.

Int J Cancer. 1997 Jul 29;72(3):416-23.

PMID:
9247284
[PubMed - indexed for MEDLINE]
12.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk